Company Filing History:
Years Active: 2024
Title: Inventor Spotlight: Daniel von Laufenberg
Introduction
Daniel von Laufenberg, an accomplished inventor located in Seiburg, Germany, is recognized for his significant contributions to pharmaceutical developments. With a focus on innovative sulfonamide compounds, his work addresses critical health challenges, particularly within the central nervous system (CNS).
Latest Patents
Daniel holds a patent for "Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides." This patent discloses novel sulfonamide compounds that exhibit GPR17 modulating properties. These compounds are particularly promising for the treatment and prevention of various CNS diseases and disorders, with a special emphasis on myelinating diseases.
Career Highlights
Currently, Daniel is employed at UCB Pharma GmbH, where he continues to make strides in pharmaceutical research and development. His innovative approach and dedication have positioned him as a key contributor to the company's efforts in addressing complex medical conditions.
Collaborations
Throughout his career, Daniel has collaborated with notable professionals in the field, including his coworkers Christa E. Mueller and Cécile Pegurier. These collaborations have enhanced the depth and breadth of his research, facilitating the advancement of new therapeutic solutions.
Conclusion
Daniel von Laufenberg's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts underscore the importance of research in developing effective treatments. His work not only exemplifies individual ingenuity but also highlights the power of teamwork in driving advancements in medical science.